Article

A primary human muscle cell-based assay for detecting myasthenia gravis autoantibody binding and assessing AChR cluster impairment

2026-08-13

Abstract excerpt

Myasthenia gravis (MG) is an autoimmune disease caused by pathogenic autoantibodies against proteins at the neuromuscular junction (NMJ). The diagnosis and clinical management of MG patients largely relies on the detection of antigen-specific autoantibodies targeting acetylcholine receptor (AChR) or muscle-specific kinase (MuSK). Yet a subset of patients remains seronegative for known MG autoantibodies, highlighti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0abd4fe1-144f-5bfc-8fac-ceedbd60a6d4
DOI: 10.64898/2026.08.10.743478

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A primary human muscle cell-based assay for detecting myasthenia gravis autoantibody binding and assessing AChR cluster impairmentDOI 10.64898/2026.08.10.743478Read

Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravisSemantic proximity Read

Heterogeneity of acetylcholine receptor autoantibody-mediated complement activity in patients with myasthenia gravisSemantic proximity Read

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsSemantic proximity Read

Evaluating an In-House Cell-Based Assay for Detecting Antibodies Against Muscle-Specific Tyrosine Kinase in Myasthenia GravisSemantic proximity Read

The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junctionSemantic proximity Read

Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia GravisSemantic proximity Read

Timing and localization of myasthenia gravis-related gene expressionSemantic proximity Read

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.Semantic proximity Read

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapySemantic proximity Read

Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis PatientsSemantic proximity Read